Analyst Ratings for Haemonetics (HAE)
HAE Rating Summary
HAE Price Target Summary
- Highest: $100.00 (Citizens)
- Lowest: $74.00 (JPMorgan)
- Average: $84.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$84.50 (+31.8%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
Percentile Rank: 46%
Avg. $ Target:
$84.50 (+31.8%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
Percentile Rank: 46%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/15/2025 | Needham | Mike Matson | Downgrade | Hold (Buy) |
N/A (N/A) |
83.49 (64.13) |
-23.19% | Details |
| 12/11/2025 | Citi | Joanne Wuensch | Downgrade | Neutral (Buy) |
88.00 (77.00) |
87.16 (64.13) |
-26.42% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
